Mucosal Vaccines - Aptimmune

Aptimmune’s revolutionary mucosal vaccines provide advantages over conventional injectable vaccines currently on the market.

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

How Aptimmune’s mucosal vaccines work:

A few facts about mucosal vaccines:

Vaccine is presented in a manner consistent with natural infection.
More than 75 percent of immune cells reside near the mucosal surface where initial infection occurs.
Elicits both innate and adaptive immunity.
Provides a fast immune response leading to immediate neutralization of disease-causing pathogens.
Elicited immune response is not inhibited by maternally-derived antibodies.
Vaccine can be used at early-age.